GB2440039A — Devices, systems and methods for medicament delivery
Assigned to Intelliject Inc · Expires 2008-01-16 · 18y expired
What this patent protects
Certain exemplary embodimets can comprise an auto-injector (1000), which can comprise: a vial (4300) configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing (1800) comprising the vial. In various embodiments, the inje…
USPTO Abstract
Certain exemplary embodimets can comprise an auto-injector (1000), which can comprise: a vial (4300) configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing (1800) comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-veno hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.